Showing results (11-20 of 76) with videos related to

Sort By:
Pageof 8
Proceedings of the National Academy of Sciences of the United States of America|November 19, 2003
The isoniazid-NAD adduct is a slow, tight-binding inhibitor of InhA, the Mycobacterium tuberculosis enoyl reductase: adduct affinity and drug resistanceRicha Rawat, Adrian Whitty, Peter J Tonge
Organic & Biomolecular Chemistry|September 7, 2017
Progress towards the broad use of non-peptide synthetic macrocycles in drug discoveryAdrian Whitty, Lauren A Viarengo, Mengqi Zhong
Biochemistry|October 24, 2012
Binding efficiency of protein-protein complexesEric S Day, Shaun M Cote, Adrian Whitty
Proceedings of the National Academy of Sciences of the United States of America|December 1, 2023
MEnTaT: A machine-learning approach for the identification of mutations to increase protein stabilitySamantha N Muellers, Karen N Allen, Adrian Whitty
Journal of Medicinal Chemistry|June 13, 2019
Why Some Targets Benefit from beyond Rule of Five DrugsMegan Egbert, Adrian Whitty, György M Keserű, et al.
Trends in Pharmacological Sciences|November 6, 2015
Lessons from Hot Spot Analysis for Fragment-Based Drug DiscoveryDavid R Hall, Dima Kozakov, Adrian Whitty, et al.
Nature Reviews. Drug Discovery|April 2, 2011
The resurgence of covalent drugsJuswinder Singh, Russell C Petter, Thomas A Baillie, et al.
Methods in Molecular Biology (Clifton, N.J.)|June 19, 2016
Characterization of Inhibitor Binding Through Multiple Inhibitor Analysis: A Novel Local Fitting MethodThomas V Riera, Tim J Wigle, Robert A Copeland
Current Opinion in Chemical Biology|May 26, 2018
Cryptic binding sites on proteins: definition, detection, and druggabilitySandor Vajda, Dmitri Beglov, Amanda E Wakefield, et al.
Pageof 8